HTT and neoplasm: Here, we also observed a 40% silencing of mouse Htt mRNA, equivalent to the silencing in normal brain cells from the xenografted striatum (Figure 2E), functionally confirming that ICV administration of ASOs is not impaired by tumor xenografts at this point in the tumor timeline.